Schoevaerdts J C, Jaumin P, Ponlot R, Chalant C H, Grunkemeier G L
Thorac Cardiovasc Surg. 1979 Feb;27(1):45-7. doi: 10.1055/s-0028-1096217.
Over a 12 year period in 230 patients mitral valve replacement was performed using the model 6120 Starr-Edwards prosthesis. Operative mortality was 6.5%, mean follow-up of the operative survivors was 3.9 years. Estimated late survival rate was 80% at 5 years and 73% at 12 years. 38% of late deaths were considered valve-related. Under routine anticoagulation thromboembolism occurred at a rate of 4.7% per patient-year with a fatal thromboembolic incidence of 1.4% per patient-year. In comparison with data available on other currently used prosthetic valves it appears that the rates of valve-related complications are quite similar, with the 6120 Starr-Edwards model being subject to the longest follow-up.
在12年期间,对230例患者使用6120型斯塔尔-爱德华兹人工心脏瓣膜进行二尖瓣置换术。手术死亡率为6.5%,手术存活者的平均随访时间为3.9年。估计5年时的晚期生存率为80%,12年时为73%。38%的晚期死亡被认为与瓣膜相关。在常规抗凝治疗下,血栓栓塞发生率为每年4.7%/患者,致命性血栓栓塞发生率为每年1.4%/患者。与目前使用的其他人工心脏瓣膜的可用数据相比,瓣膜相关并发症的发生率似乎相当相似,6120型斯塔尔-爱德华兹人工心脏瓣膜接受随访的时间最长。